Patent application number | Description | Published |
20090176166 | METHOD FOR MANUFACTURING PHOTOMASKS AND DEVICE FOR ITS IMPLEMENTATION - The photomask manufacturing method comprises at least one step of cleaning the photomask and at least one step of placing a protective pellicle onto the photomask at the end of manufacturing. The inventive method further comprises at least one step of removing ammonia and sulfate residue between the cleaning step and the pellicle placement step. This step comprises the following operations:
| 07-09-2009 |
20090263216 | Method and Device for Removing Pollution From a Confined Environment - The subject of the present invention is a method for removing pollution from a confined environment containing an interior space bounded by a wall, involving the following steps:
| 10-22-2009 |
20100006472 | Drain device and method - The present invention provides a drain device for a transporting box with an input/output opening which can be blocked by a box door and which contains substrate wafers stacked according to parallel planes. The drain device comprises a volume limited by a sealed wall divided into at least an upper part with a purging gas inlet orifice and a lower part with a purging gas outlet orifice, with the two parts being separated by a sealed partition, and a range of guides defining the openings arranged parallel to those of the wafers and connecting with the volume of the drain device to direct the purging gas towards the transporting box. | 01-14-2010 |
20110048143 | CONTAMINATION MEASUREMENT STATION AND METHOD FOR A SEMICONDUCTOR SUBSTRATES TRANSPORT POD - The invention concerns a measurement station for the measurement of particle contamination of a transport pod for the conveyance and atmospheric storage of semiconductor substrates, such pod comprising a casing capable of being closed by means of a removable access door, such station comprising:
| 03-03-2011 |
20120090382 | DEVICE AND METHOD FOR ANALYSING GAS AND ASSOCIATED MEASUREMENT STATION - The invention relates to a station for measuring gaseous pollution in a transport enclosure of semiconductor substrates comprising a gas analysis device for determining the concentration of the gas to be analysed, said analysis device including: a diluting unit ( | 04-19-2012 |
20120259449 | Method and Device for Controlling the Manufacture of Semiconductor by Measuring Contamination - A device for handling substrates within a semiconductor manufacturing plant having substrate processing equipments, substrate storage means, substrate transport means, and a manufacturing execution system (MES) functionally related with the substrate processing equipments, the substrate storage means and the substrate transport means, including at least one substrate storage and transport box that is transported by the transport means and stored in the storage means; at least one gas analysis device of the gases forming the internal atmosphere of the substrate storage and transport box, which produces analysis signals representative of the quantity of the critical gas that is likely to generate molecular contamination, which is present in the storage and transport box; and an execution device which pilots the transport means and the storage means, with the execution device comprising instructions for detecting a molecular decontamination need as a function of analysis signals emitted by the gas analysis device. | 10-11-2012 |
20130097802 | Treatment Device For Transport And Storage Boxes - A treatment device for transport and storage boxes according to the invention comprises a plurality of decontamination modules ( | 04-25-2013 |
20130152977 | Method And Device for The Depollution Of A Pelliculated Reticle - The object of the present invention is a device for depolluting a non-sealed, confined environment ( | 06-20-2013 |
20140294609 | GAS PUMPING AND TREATMENT DEVICE - A device for pumping and treating gases is disclosed. The device features a stator having a plurality of pumping stages connected in series one after another between a suction side and a delivery side by the inter-stage ducts. The device also includes an inner tube and a blind outer tube, the tubes inserted one inside the other and made of ceramic material, the inner tube connected to the delivery side of the rotor housing of a pumping stage and the outer tube connected to the stator and communicating with at least one inter-stage duct formed in the stator, the tubes defining a path for the pumped gases. The device also includes a plasma source located outside the stator to generate a plasma in the path of the pumped gases. | 10-02-2014 |
20150276572 | STATION AND METHOD FOR MEASURING PARTICLE CONTAMINATION OF A TRANSPORT CARRIER FOR CONVEYING AND STORING SEMICONDUCTOR SUBSTRATES AT ATMOSPHERIC PRESSURE - The present invention relates to a station for measuring particle contamination of a transport carrier for conveying and storing semiconductor substrates at atmospheric pressure, said transport carrier comprising a rigid casing ( | 10-01-2015 |
Patent application number | Description | Published |
20090232851 | SIMULTANEOUS, SEPARATE OR SEQUENTIAL THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN AND OF AT LEAST ONE OPIATE DERIVATIVE - The present invention relates to a composition comprising: at least one botulinum neurotoxin, and at least one opiate derivative or its salt. The invention also relates to a product comprising at least one botulinum neurotoxin and at least one opiate derivative or its salt, as a combination product for simultaneous, separate or sequential therapeutic use in the treatment or prevention of pain and of neuromuscular disorders. | 09-17-2009 |
20090270400 | PAINKILLING ASSOCIATION COMPRISING A DIHYDROIMIDAZOPYRAZINE DERIVATIVE - The invention relates to a product comprising (1R)-1-[(({2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl) -2-phenyl-5,6-dihydroimidazo [1,2-a]pyrazin-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl) -2-phenyl-5,6-dihydrolmidazo[1,2-a]pyrazin-7(8H)-yl]-2-oxoethylamine in association with an analgesic agent selected from morphine, the similar or a morphine derivative, sodium channel inhibitors, non-steroidal antiflammatory agents (AINS), glutamatergic system inhibitors, tricycle antidepressants and gabaergic derivatives for simultaneous therapeutic use which is separated or out over the time for pain treatment or prevention. | 10-29-2009 |
20090270401 | USE OF A DIHYDROIMIDAZOPYRAZOINE DERIVATIVE FOR TREATING OR PREVENTING PAIN - The invention relates to the use of (1R)-1-[({(2R)-2-amino-3-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-yl]-3-oxopropyl}dithio)methyl]-2-[(8S)-8-(cyclohexylmethyl)-2-phenyl-5,6-dihydroimidazo[1,2-a]pyrazine-7(8H)-yl]-2-oxoethylamine or an pharmaceutically acceptable salt thereof for preparing a drug for preventing or treating pain. | 10-29-2009 |
20100029566 | USE OF AT LEAST ONE BOTULINUM NEUROTOXIN FOR TREATING THE PAIN INDUCED BY THERAPEUTIC TREATMENTS FOR THE AIDS VIRUS - The present invention relates to the use of at least one botulinum neurotoxin for the production of a medicament for treating or preventing pain induced by a medicament used for treating the AIDS virus. | 02-04-2010 |
20100068231 | Therapeutic use of at least one botulinum neurotoxin in the treatment of pain induced by at least one anti-neoplastic agent - The present invention relates to a method of treating or preventing pain or pains induced by an anti-neoplastic agent, comprising the step of administering an effective amount of at least one botulinum neurotoxin to a patient in need thereof. | 03-18-2010 |
20110038893 | THERAPEUTIC USE OF AT LEAST ONE BOTULINUM NEUROTOXIN IN THE TREATMENT OF PAIN ASSOCIATED WITH DIABETIC NEUROPATHY - The present invention relates to at least one botulinum neurotoxin for treatment of prevention of pain associated with diabetic neuropathy wherein said botulinum neurotoxin is prepared for local administration, wherein the local administration is not in the central nervous system (CNS), and wherein pain is treated at a site distant to the site of administration. | 02-17-2011 |
20140154781 | Therapeutic Use of Botulinum Neurotoxin in the Treatment of pain associated with diabetic neuropathy - The present invention relates to at least one botulinum neurotoxin for treatment or prevention of pain associated with diabetic neuropathy wherein said botulinum neurotoxin is prepared for local administration, wherein the local administration is not in the central nervous system (CNS), and wherein pain is treated at a site distant to the site of administration. | 06-05-2014 |
Patent application number | Description | Published |
20100092417 | MASCARA COMPOSITION COMPRISING AN ETHYLENE/VINYL ACETATE COPOLYMER - The present invention relates to a mascara composition including a cosmetically acceptable aqueous medium, characterized in that it includes an oily phase including at least one ethylene/vinyl acetate copolymer, and at least one wax or a mixture of waxes in a certain weight ratio. The present invention also relates to a process for the care or make-up of eyelashes or eyebrows, characterized by the fact that a composition according to the invention is applied to the eyelashes or eyebrows. It also relates to the use of a composition according to the invention in order to obtain a make-up for filling and/or curling the eyelashes and/or a smooth and uniform deposition on the eyelashes. | 04-15-2010 |
20100172852 | COSMETIC COMPOSITION COMPRISING AN EXTRACT OF CHINESE INSECT WAX - A cosmetic composition in solid form includes 25-90% of at least one silicone oil and an extract of | 07-08-2010 |
20100254933 | COSMETIC COMPOSITION CONTAINING A POLYAMIDE RESIN, A GLYCERYL ESTER AND AN APOLAR WAX - A cosmetic composition includes, in a physiologically acceptable medium: (a) at least one polyamide resin bearing end groups with a tertiary amide or ester function; (b) at least one ester obtained from: (i) a saturated or unsaturated, linear or branched, aliphatic acid or hydroxy acid containing from 8 to 30 carbon atoms, (ii) a linear or branched diacid containing from 12 to 36 carbon atoms, and (iii) glycerol or a glycerol condensate; and (c) at least one apolar wax. It also relates to a cosmetic process for making up the lips, including the topical application of this composition to the lips. | 10-07-2010 |
20120148645 | COSMETIC COMPOSITION BASED ON SUBSTANTIALLY HEMISPHERICAL PARTICLES - Disclosed is a cosmetic composition including, in a cosmetically acceptable medium, the combination of (a) a sufficient amount of uncoated substantially hemispherical PMMA particles and (b) a sufficient amount of substantially hemispherical PMMA particles coated with optionally treated metal oxide. It also relates to its uses in caring for or making up the skin. | 06-14-2012 |